^(99m)锝-亚甲基二磷酸盐骨定量测定在骨质疏松症中的研究进展  

Progress of quantitative measurement of bone using ^(99m)Tc-methylene diphosphonate in osteoporosis

作　　者：姚玉唐 欧晓红[1] 

机构地区：[1]四川大学华西医院核医学科,成都610041

出　　处：《生物医学工程学杂志》2017年第5期812-816,共5页Journal of Biomedical Engineering

摘　　要：骨质疏松症(OP)发病率逐年增加,骨质疏松性骨折引发的高致残率及高致死率已成为我国乃至全球面临的重大医疗卫生问题。放射性核素^(99m)锝-亚甲基二磷酸盐(^(99m)Tc-MDP)骨定量测定能提供全身或局部骨骼骨代谢或转化的信息。本文就放射性核素^(99m)Tc-MDP骨定量测定方法进行简述,以期能为临床诊疗提供参考。As the incidence of osteoporosis （OP） is increasing year by year, high morbidity and mortality caused by osteoporotic fractures have become major problems of health in China and over the world. Quantitative measurement of bone using 99m^Tc-methylene diphosphonate （99m^Tc-MDP） provides global or local information of skeletal metabolism or transformation. In this paper, we make a brief review on the quantitative measurement of bone using 99m^TC-NIDP and expect to provide guidance for clinical diagnosis and treatment.

关 键 词：骨质疏松症 骨转换 放射性核素骨定量测定 99m^锝-亚甲基二磷酸盐 标准化摄取值 

分 类 号：R580[医药卫生—内分泌] R817.4[医药卫生—内科学]